Kidney stones

Lactobacillus reuteri – LRE02 (DSM 23878)

Production of reuterin and vitamin B12 • Anti-pathogen activity and immunostimulation (induction of IFN-gamma) • Oxalate degradation • Reduction of intestinal inflammation • Potential reduction of kidney stones incidence

Lactobacillus plantarum – LP01 (LMG P-21021)

Constipation • Intestinal transit • Leaky gut • Inhibition of E. coli• Antioxidant activity • Reduced glutathione (GSH) and superoxide dismutase (SOD) production • Cystitis • Inhibition of E. coli…

Lactobacillus paracasei – LPC09 (DSM 24243)

Oxalate degradation • Reduction of intestinal inflammation • Potential reduction of kidney stones incidence

Lactobacillus acidophilus – LA02 (DSM 21717)

 Rebalance of intestinal microbiota • Oxalate degradation • Reduction of intestinal inflammation • Potential reduction of kidney stones incidence 

Bifidobacterium longum – BL03 (DSM 16603)

Constipation • Intestinal transit • Oxalate degradation • Reduction of intestinal inflammation • Potential reduction of kidney stones incidence

Bifidobacterium breve – BR03 (DSM 16604)

Constipation • Intestinal transit • Anti-inflammatory • Reduction of gastro-intestinal discomfort • Inhibition of pathogenic E. coli • Restoration of a better dietary ω-6/ω-3 balance • Conjugated linoleic acids (CLA) production…

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top